<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for The Medical Centre</h1>
        This is some intro text. Please fill in our feedback <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=%20">survey</a>.

        <h2>Prescribing where The Medical Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=1003020Y0&amp;denomIds=10.3.2&amp;selectedTab=summary">Freeze sprays and gels</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>433</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>38.92</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=1003020Y0BDABAC&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Deep Freeze Cold Gel 2% : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0803042H0&amp;denomIds=8.3.4&amp;selectedTab=summary">Flutamide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Prostate cancer and gonadorelin analogues</td>
      <td>39</td>
      <td>0.05</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>14.39</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0803042H0AAAAAA&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Flutamide 250mg tablets : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=1104020N0&amp;denomIds=11.4.2&amp;selectedTab=summary">Nedocromil sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Other anti-inflammatory preparations</td>
      <td>73</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>9.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=1104020N0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Nedocromil 2% eye drops : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=1003020F0&amp;denomIds=10.3.2&amp;selectedTab=summary">Benzydamine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>433</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>8.29</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAJYklEQVR4nO2de7BVVR3HPwsQLJCIUO4f3dwRMKXZA1+BaYg81JUNCdig6fTCNGsqG3WrA1kmLgdDByfxUWhgaVZG6nZISB4aj5GSYTSJcNwjmQIJgg/A1+qP3zq5O8OFe+7Z+55z7/59Ztbsy9lnr99vcfZ3rbXX+q21jfceRVHKQY9GO6AoSuehgleUEqGCV5QSoYJXlBKhgleUEqGCV5QSoYJXlBKhgleUEqGCV5QSoYJXlBJRn+CN0bhcRelC9Gq0A1Gc9ATGAV8BngeuTJ3d01CnFKWbYupaPGOMx3vTkUujOBkKfBWYCqwH7gBOQMR/durs0x13TFGUfdEpgo/ixACtwGeAkYiw34OI/K7U2a2Z704A5gLXAPNSZ/WxQVFyolDBB6HPBU4DtgOrgNXhuKktMUdx0gL8EtgBXJA6+3LHnVQUpULRgj8GmAOMT519tZasozjpAfwA6fKPTJ3d23FHFUWB4qflzkO65TWJHSB19p3U2VnAMmBm3o4pShkpTPBRnBwETAR+W2dWVwBjojgZV79XilJuimzhTwVWpc7urCeTMEX3ZeCWKE4G5eKZopSUIgV/LjA/j4xSZ58CZgM/DwOBiqJ0gEIEH8XJAGQK7uEcs70ZOAiYlmOeilIqimrhpwD3pc6+mVeGYQrva0AcxclH88pXUcpEUYI/D1iQd6aps1uAbwP3RnFyfN75K0p3J/d5+ChOhgD3A0cVFSUXxYkFpgOvAdcCf9aIPEU5MEUIfgawN3X2ujp92y9h8O5k4HLgfYjwF6rwFaVtchV8EOEG4JTU2X/V7177iOLkWGAGIvwLw6i+oihV5C34kcDVqbNjc/CtZqI4OQOZvvtd8OP1RvihKM1K3oN251LAYF17SZ19APgUYIB14VlfUZRAbi18FCd9gE3AEamzr+TjXseJ4uTjwG3AotTZHzfaH0VpBvJs4ccBjzWD2AFSZ59EfJoSxckpjfZHUZqBPAU/mfoXyuRK6uxryPLa26M4GdxofxSl0eQi+ChOegNjgUV55JcnoaWfCdwV1tgrSmnJSwBjgJVNPCr+C2ArMmevKKUlL8FPRqbCmpIQjHMBcE4UJyc22h9FaRR1Cz5sdDEBeKh+d4ojDCaeDdyh6+qVspJHC/854PGObGPV2aTOrgOuB1ZEcfKtsIxXUUpDHoJv6u58NamztwBnAUOB9VGcLIjiZLRurKGUgTwEfzrwYA75dBqps0+mzl4MDENW9sWI+I9urGeKUix1R9pFlz34QOrsF/JzqTFEcTIKuBP4GTBHV90p3ZE8Wvjf55BHw0mdXYlsyzUaWBjFycDGetR+ojjp22gflK5BHoK/P4c8moLU2e3AmcASYE0UJyc02KX9EsVJvyhOZgNbojhx4cWcitImDXuZZLMTxckI4FfA7cANzdbFj+LkVOStPr8BfgrcCLQAU1NndzTSN6V5UcHvhzBttwB4FfhGiM3vaF6HAp8FjkHerfdw6uwbHcjnMOAGYAgwLYQOVzYf+Q5wITCl8rmiZFHBH4AQfz8d+CIwKXX2mXZe1xc4A4lTOAnoBTwKPAGciLxBdxFwN7A8dfbtA+TXG/gmcDHSos/d1zVRnIwG5gGXhPwj4MOZ9F7kJZ3Z9G/gidTZ3e0pm9J1UcG3kyhOPg/cBFyUOttmVGEUJ8ORVnYyIrjFwKOpsy9Ufa8fUiFMBT4B/BER/5rs40NouScBPwFWAD+szmsfPhwe8moBUuDZTHodGAC8P5NagRHAC0jvY2U4bm62R5lGEMVJBIwC1qbObmywO3Whgq+BKE6GIrMSO4FnqlILcBHwQeQV2fNTZ3e1M9+BSA9iKnA4Esh0N9AfmAVsA+LU2b/nWZ4qHwzymDAykz4APM67FcDfustbfKM46Y/0vlqBLSG9GBLIbM0EYDxSSa4CjgP6APeFtL6rVYgq+BoJawc+UpWGIDfFrcDSem6CKE5akBd5TA0fXZE6u6wen+vwpR9wLO9WAJ8GPLArk3Yi24XvAfaG4x7gZeBp4Cng+X30WgYDHwOGIxVbn5B6h2NPZKsyMsfdwGbguZA2A9sqeYd8DTL71CPkkf37KGQZ91ikYl6O7NJ0GFJhtwS/eiOPX38CFqfOViqBSms/Eel1DUZ6cMuQx7Kttfz/doTwqDgCOB55RNuVOtvuVaAqeKUmojjpBRyC7BDcPxz7IiI9OKQ+wCDgCOBIREjPIo8XEXKjbkN2ON6AVA57Q3ojHN/KmK3cpH2RFrkV+FBI1Quh3gHeDsfqtBER6BJgQ72tc9hU5WSkNzA62F2OVHK7Q9oTjtmeUbVmTNXfByNjLX0zaQgi8oHAX4E1wD+BQ1Jn72y30977Difg/Hqu72p2tcxqt6vbrjfw5vw6r+9qdhtpW8vc/e0Wblu3fFKUEqGCV5QSUa/gb8vFi65jt5G2tczd327htusbpVcUpUuhXXpFKRG9avmyMeYkJMRwq/d+njHmTCTwZJP3/g9FOJixPRF5b9xG7/2vjTGzkeCLe7z3L+7/6rrsfg+pGFd479caY76OBFws997/pSi7wfYYJOz2SO/9tKLLbIwZjezuOwM4B9jhvb8xnPu/375A27cGO6947+eEc1chc/UPee9zDW3N2L0HWdj0iPf+kXCu0Ps7Y/t6ZGHVKO/9WeHcVRRQ5lpb+JHeewccGv49zHs/C4mWKhTv/UJk0Uhr+OgloB8SUFEk25HIq0rlOMh7PxP5gQol3HirkTh7KLjM3vtlwDrAIrH7fTKnq3/7Qmx775cCDgnrrfASEnxSmF0kWvBNJOilQqH3d6bMa4F7gaWZ04WUuVbBVz/wd9oAgDGmJ3ApEqeO9/4aZDHLl4q0672fH270yiuwO3vQYzwS4tlpZW6Dziz3pcg+BGLY+5uAa5EFSYXgvV/svf8RErb6v4+LsrcPJpHZPaqoMtfUpQdWG2MuA7YbY44GNhljLgH+kadTbXA14u/3jTHzkFZoKLJJRWEYYyzS1XvLGNMK/McYczmycq1QQiXXAzjOGPMcBZfZGPNJZNnuEuBKYIcxZgCy9Vflty8kXrxi2xjzXcIiHmPMOiR8dzgSovtYgXanIwLfaYwZFuwWen9nbJ8GDPbeb83YLqTMOkqvKCVCR+kVpUSo4BWlRKjgFaVEqOAVpUSo4BWlRKjgFaVEqOAVpUSo4BWlRKjgFaVEqOAVpUSo4BWlRPwXtJY0m8XfGeIAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=1003020F0AAAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Benzydamine 3% cream : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0206020M0&amp;denomIds=2.6.2&amp;selectedTab=summary">Nimodipine</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Calcium-channel blockers</td>
      <td>3844</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>8.18</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0206020M0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Nimodipine 30mg tablets : 3</a></div></td></tr></tbody></table>

        <h2>Prescribing where The Medical Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=091101000&amp;denomIds=9.11.1&amp;selectedTab=summary">Other amino acidandnutritional agent preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Amino acids and nutritional agents</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.95</td>
      <td>0.20</td>
      <td>-4.82</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0501021L0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefalexin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>24</td>
      <td>Cephalosporins</td>
      <td>34</td>
      <td>0.71</td>
      <td>0.96</td>
      <td>0.10</td>
      <td>-2.48</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0501021L0AAACAC&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 125mg/5ml oral suspension : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0501021L0AAABAB&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg capsules : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0501021L0AAAAAA&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg capsules : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0501021L0AAAGAG&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0501021L0AAAHAH&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0401020K0&amp;denomIds=4.1.2&amp;selectedTab=summary">Diazepam</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>80</td>
      <td>Anxiolytics</td>
      <td>188</td>
      <td>0.43</td>
      <td>0.75</td>
      <td>0.14</td>
      <td>-2.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0401020K0AAAHAH&amp;denomIds=4.1.2&amp;selectedTab=summary" target="_blank">Diazepam 2mg tablets : 68</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0401020K0AAAWAW&amp;denomIds=4.1.2&amp;selectedTab=summary" target="_blank">Diazepam 2mg/5ml oral solution sugar free : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0401020K0AAAIAI&amp;denomIds=4.1.2&amp;selectedTab=summary" target="_blank">Diazepam 5mg tablets : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0&amp;denomIds=1.1.2&amp;selectedTab=summary">Alginic acid compound preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>940</td>
      <td>Compound Alginates and proprietary indigestion preparations</td>
      <td>970</td>
      <td>0.97</td>
      <td>1.00</td>
      <td>0.01</td>
      <td>-2.03</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0AAALAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg/5ml susp SF : 152</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEAIAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral suspension aniseed (Reckitt Benckiser) : 184</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEBEAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral susp peppermint (Reckitt Benckiser) : 245</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BIAAAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid aniseed : 83</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BIABAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid peppermint : 148</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEAFAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint Liquid Relief : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEADAJ&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Infant oral powder sachets : 23</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEARA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action chewable tablets mint : 13</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEAQAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance Mint chewable tablets (Reckitt Benckiser) : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEACAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Original Aniseed Relief : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0AAAPAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg chew tab SF : 26</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0BEAUAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint chewable tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0101021B0AAAHAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Alginate raft-forming oral suspension sugar free : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0&amp;denomIds=3.1.1&amp;selectedTab=summary">Salbutamol</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1802</td>
      <td>Selective beta(2)-agonists</td>
      <td>2211</td>
      <td>0.82</td>
      <td>0.91</td>
      <td>0.05</td>
      <td>-1.99</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAH90lEQVR4nO2dX4xcVR3HP2fbAktpq5UCBVovlq1IrZQ/GlukgPA2PBAfjMYEH0iMTxgftNdgIglKhhCNkQeNJiSSaOyL8MDVlzYppQGEYpv0D3W7kGttqa61xSJibenx4XfGmR1n6+7OmT9n7/eTnJyd3XZ+587M5zf3nnv+OO89QohqMDLoBggh+oeEF6JCSHghKoSEF6JCSHghKoSEF6JCSHghKoSEF6JCSHghKoSEF6JCSPgUcE7jn0UUFnb7BFlebAaWhrKkpR4FLgYumaZehCWcRnEdHp8DzobS+nOjvAe801JOd3j811BOl/WaxBGVxnU7eSbLi62YWA3ZGvV7wBngX6GcaavPAe8D5wEf6vMtjz2WkBZdoIxiyaVRlnZ4fDlwRfj5HM0EMBnq48AR4E+hHC/rtXNdvSixcc7jvRt0M0T6dC18SmR5cRGWAFZgSeAK4GpgVUtZiSWGo1giOAK8ARwGJoBjZb12vq8Nl/AiEpUSfqZkeXEJcC2WAFYD1wNjob4GOIHJf7ilPgy81ZNkIOFFJCT8LMnywmFnCWM0k8B0yaA1IRybcx+ChBeRkPARuUAyWItdKhwFDoXyeqgnynrt3xd8YgkvIiHh+0SWFyPYZcINwMda6uuBd5maBA4Bh8p67W1AwotoSPghIMuLD2IJoD0ZjALj5eP33Z1tee5rwH7gADCpW4xiLkj4ISbLi4uBsfLx+/ZlW577DrAulOXAOM0EcADYX9ZrJwfWWJEEEj4F2k7pw+3FMUz+j7fUl2KXAwdoSQZlvXa6720WQ4mET4EZXsOH24kfZWoSWIcNYDoI7AP2hjI+dAOMRM+R8CnQZaddlheLsT6B9cCGUNZig4r2AntCva+s197tvsFiWJHwKdCDXvpw1yDD5L851OuxIdGtSWBvWa9NxowtBoeET4E+3pbL8mIFcBPNJLABm5fQuBz4PbAbOKI7Bekh4VNgwPfhs7y4FOsP2ADcCtwGXIklgFeBV4BXy3rtxKDaKGaGhE+BIRx4k+XFKHYm8EngU6FeBLwGvAy8COwp67UzA2uk+B8kfAoMofCdyPJiGfbt/2lgI3ZZUGLyvwS8WNZrfx5YA4WET4JEhG8ndAyuBTZhCWATtgDKS8DzoRxWX0D/kPApkKjwnQjDiDcBm4E7sfUIWhPAQSWA3iHhU2AeCd9OlheXYQngTiwJXAf8DtgObENnAFGR8Ckwj4VvJ3QGbgQ+C9yL3Q3Ygcm/XX0A3SHhU6BCwreT5cUHgLsw+e/FFi/dFsrOsl57Z3CtSw8JnwIVFr6dLC9WAfdg8m8G/kgzAbxS1mtnB9i8oUfCp4CE70hYYWgdzQRwCzYSsJEA1AHYhoRPAQk/I7K8WIQNAmqc/q8GdtK8/j86wOYNBRI+BST8nMjyYgl22t9IAAtpfvvvKOu1vw+weQNBwqeAhI9Clhcrafb+3w38BXgB2AXsqsJcAAmfAhI+OuH6fw1wB/CZUN7H5G8kgXK+9QFI+BSQ8H0hy4uraMp/B/AhbDLQ7lBeS33dQAmfAhJ+IIQ+gJuxCUGNMsLUJLDnv8uJJ4CETwEJPzSEgUC30EwAG7DdkA/RXDh0P3ZL8B+Daud0SPgUkPBDTRgOfANTFw+9Edvy/CC2pHhj27EJbLWggSwgKuFTQMInSZgYdCPNbccaW4+txrZUbySAN7ERg41yqledhRI+BST8vCNME16DJYCPYEngw6EsxzYlbU0Cx0J5C9uYdE5zCCR8Ckj4StGyKWlrErga2524US8B3sbkv2emzy3hU0DCizZCUlgGXFPWawdm+v8kfApIeBGJkW6fwDn3lRgNGcZ4QxOrB7IPzbElHKvf8WLE6lp4oK8vcJ/jzddY/Y43X2P1O95QCC+ESAQJL0SFiCH8TyM8x7DGm6+x+h1vvsbqd7yuY6mXXogKoVN6ISrEwtn8Y+fcZmzTgEnv/VPOuc9hwwMnsFlCXwJOee9/GKNxHeJ9GZuc8FtsI8MRYKf3fncPYj2CjWT6DXBV6996EOt+bMz1KPA3Ih5XiHcX8FXv/RfC4wex9d6fBxYQ99jaYz2EDR/9MfB5wmvqvR/vQawfAEeAX2HHtAaY8N4/022saeI9AKwH/gBcS9xjux+biTfuvf9lrPdstt/wG733dWBFeDzmvX8C2z+sBnwXmyoYiynxvPc/B36CjT0+CVzELJPWTGNh4i2e5m9RY3nvnwXeALYS/7jw3u/AtnZucLn3/jFsoYeox9Yey3v/I+AZYCVTX9PoscLzXwacZ+pnsyfxvPdPA8eBXxP/2J4Fvg+sCr+K8p7N9kPVfsHf6w6AKc/vnFsMPAg84r0/G373bWx74qixvPdPOudGgByIPZWx0+u23nu/FZtLHfO4/l/8nr6Hzrkrgdu9948C21te08dix/Lef885twx4gN5/Nhss996fBJ6MeWzOuQXAN4Enwq+ivGezFf5l59wW4KRz7lZgwjn3DeyU5nXgYeDUXBszg3gPYZcPtznnlmMLEEz0KNZa7PJhF/DP8LfJHsV6E/tmxzlXI+5x4Zy7CbjdOfcw8DRwwjn3LWwJ5wUxj61DrJ8B25xz64BP0HxNexGrhk1B/QVwXctnMwod4i2lmaC/SMRjAx7F/Py6c+4pIr1n6qUXokKol16ICiHhhagQEl6ICiHhhagQEl6ICiHhhagQEl6ICiHhhagQEl6ICiHhhagQEl6ICvEfxI5t9gNgf/MAAAAASUVORK5CYII="></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0AAAPAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose inhaler CFC free : 1156</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0AAAXAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials : 69</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0AABUBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose breath actuated inh CFC free : 86</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0BEAIAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 100micrograms/dose Evohaler : 78</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0BWAABZ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 100micrograms/dose dry pdr inh : 329</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0BMABBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Airomir 100micrograms/dose Autohaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0AABDBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0AABGBG&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2mg/5ml oral solution sugar free : 21</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0BEAHAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 200micrograms/dose Accuhaler : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0BIAGBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose Easi-Breathe inhaler : 24</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=B86062&amp;numIds=0301011R0BWABAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 200micrograms/dose dry pdr inh : 5</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>